Literature DB >> 1412682

Feasibility and success of a single-donor red cell program for pediatric elective surgery patients.

R G Strauss1, M R Wieland, M J Randels, T A Koerner.   

Abstract

Although the risks of allogeneic blood transfusions are small, it is wise to limit donor exposure whenever possible. A program has been developed in which one donor provided all red cell (RBC) units for each patient awaiting elective surgery. Patients were mostly children who were ineligible for autologous blood donation. Seventy-three patients and 115 donors (mostly parents) entered the program. Of the 115 donors, 90 (78%) were eligible to participate and 25 (22%) were ineligible; 21 were ineligible because of RBC incompatibility. For each of the 73 patients, one eligible donor was selected to donate all RBC units. Preoperative RBC orders were 1 to 2 units for 41 patients and > or = 3 units for 32 patients. Of the 73 donors, 58 (79%) gave all RBC units ordered; 15 (21%) failed to complete all donations, but only 1 because of anemia (hematocrit < 33% [0.33]). Of 73 patients entered, 46 (63%) underwent transfusion, and 27 (37%) did not. Of 46 patients transfused, 38 (83%) received only single-donor RBCs. Thus, the RBC needs of nearly all pediatric elective surgery patients were provided by a single donor for each patient. Single-donor blood programs should be considered for elective surgery patients who are ineligible for autologous blood donation and who would otherwise be exposed to multiple donors.

Entities:  

Mesh:

Year:  1992        PMID: 1412682     DOI: 10.1046/j.1537-2995.1992.32893032103.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

Review 1.  Blood support for pediatric surgery.

Authors:  K Janatpour; P Holland
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 5.319

2.  Dedicated donor unit transfusions reduces donor exposure in pediatric surgery patients.

Authors:  Satyam Arora; Neelam Marwaha; Hari Krishan Dhawan; K L N Rao
Journal:  Asian J Transfus Sci       Date:  2017 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.